| Literature DB >> 26208216 |
Xiang Zheng1, Ningjing Zhang2, Xiaoshu Zhang2, Lixin Hao3, Qiru Su3, Haijun Wang4, Kongyan Meng5, Binglin Zhang2, Jianfeng Liu2, Huaqing Wang3, Huiming Luo3, Li Li3, Hui Li2, Chao Ma3.
Abstract
BACKGROUND: A measles outbreak occurred in a western county of China in 2013, the year after China's historic nadir of measles. We conducted a field investigation to identify gaps in measles vaccination coverage and immunization program weaknesses, and to provide recommendations for measles outbreak response and immunization program improvement.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26208216 PMCID: PMC4514761 DOI: 10.1371/journal.pone.0133983
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Supplementary immunization activities (SIAs) and screening-and-vaccination activities (SVA) conducted during 2008–2013, W county, China.
| Time | Category | Age range | No of vaccinated | Total | Coverage %(95% CI) |
|---|---|---|---|---|---|
| 2008 | SIA | 8 months-14 years | 87041 | 90275 | 96.4 (96.3–96.5) |
| September 2010 | SIA | 8 months-4 years | 27069 | 27268 | 99.3 (99.2–99.4) |
| September 2011 | SIA | 8 months-14 years | 89731 | 92722 | 96.8 (96.7–96.9) |
| March to April 2012 | SVA | 8 months-6 years | 5737 | 5800 | 98.9 (98.6–99.2) |
| March 2013 | SIA | 8 months-4 years | 33852 | 34984 | 96.8 (96.6–96.9) |
† An SIA conducted after the Wen-chuan great earthquake.
‡ As part of China’s nation-wide SIA in 2010
Fig 1Time distribution of measles cases by illness onset date, categorized by hospital exposure history.
Fig 2Distribution of MCV vaccination status among different age groups.
MCV coverage assessment of different age groups*.
| Age range | 0 dose | 1 dose | ≥2 doses | |||
|---|---|---|---|---|---|---|
| No. | Percentage (95% CI) | No. | Percentage (95% CI) | No. | Percentage (95% CI) | |
| 8–17 months | 22 | 19.6 (12.7–28.2) | 62 | 55.4 (45.7–64.8) | 28 | 25.0 (17.3–34.1) |
| 18–23 months | 2 | 3.5 (0.4–12.1) | 20 | 35.1 (22.9–48.9) | 35 | 61.4 (47.6–74) |
| ≥24 months | 7 | 1.9 (0.8–3.8) | 25 | 6.7 (4.4–9.7) | 341 | 91.4 (88.1–94.1) |
| sum | 31 | 5.7 (3.9–8) | 107 | 19.7 (16.5–23.3) | 404 | 74.5 (70.7–78.2) |
*The MCV doses include both routine immunization doses and SIA/SVA doses.
Distribution of MCV1 vaccination month
| Vaccination month | Number of records | % |
|---|---|---|
| 8 | 320 | 59.0 |
| 9 | 85 | 15.7 |
| 10 | 32 | 5.9 |
| 11 | 29 | 5.4 |
| 12 | 11 | 2.0 |
| 13 | 7 | 1.3 |
| 14 | 2 | 0.4 |
| 15 | 3 | 0.6 |
| 16 | 3 | 0.6 |
| 17 | 3 | 0.6 |
| ≥18 | 16 | 3.0 |
| unvaccinated | 31 | 5.7 |
| Total | 542 | 100 |
Distribution of MCV2 vaccination month.
| Vaccination month | Number of records | % |
|---|---|---|
| 9–17 | 62 | 14.8 |
| 18 | 94 | 22.5 |
| 19 | 58 | 13.9 |
| 20 | 30 | 7.2 |
| 21 | 28 | 6.7 |
| 22 | 21 | 5.0 |
| 23 | 21 | 5.0 |
| 24 | 9 | 2.2 |
| ≥25months | 53 | 12.7 |
| unvaccinated | 42 | 10.0 |
| Total | 418 | 100 |
Fig 3Hospital exposure histories prior to rash onset for 13 cases.